Insider trades
Richard A. Graham, SVP of Theravance Biopharma TBPH, has filed 0 purchases and 10 sales on the open market. The latest trade was on 24/02/20.
Richard A. Graham
SVP, Research & Development
- Company
- Theravance Biopharma TBPH
- First filing
- 23/02/22
- Trades
- 17 trades
- Buys / sales
- 0 / 10
- 12-month net buying
- No record
- Last trade
- 24/02/20
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale10b5-1 plan | 23/11/14 | 23/11/16 | 2,482 sh | $10.22 | $25,366.04 | −0.7% | |
| Open-market sale10b5-1 plan | 23/10/16 | 23/10/18 | 2,482 sh | $9.03 | $22,412.46 | −0.7% | |
| Open-market sale10b5-1 plan | 23/09/14 | 23/09/18 | 2,482 sh | $9.89 | $24,546.98 | −0.7% | |
| Open-market sale10b5-1 plan | 23/08/11 | 23/08/15 | 2,322 sh | $9.99 | $23,196.78 | −0.7% | |
| Open-market sale | 23/07/14 | 23/07/18 | 2,322 sh | $9.84 | $22,848.48 | −0.7% | |
| Open-market sale | 23/06/14 | 23/06/16 | 2,322 sh | $10.69 | $24,822.18 | −0.7% | |
| Open-market sale | 23/05/15 | 23/05/17 | 2,322 sh | $11.26 | $26,145.72 | −0.6% | |
| Open-market sale | 23/04/14 | 23/04/18 | 2,323 sh | $11.88 | $27,597.24 | −0.6% | |
| Open-market sale | 23/03/14 | 23/03/16 | 2,323 sh | $10.32 | $23,973.36 | −0.6% | |
| Open-market sale | 23/03/06 | 23/03/08 | 2,323 sh | $10.05 | $23,346.15 | −0.6% |